Purchase Order 75N94021P00072
- Not listed
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm-fixed-price delivery order contract to Agilent Technologies Inc. for a high-performance liquid chromatography (HPLC) with a single quadrupole mass spectrometer service contract. The contract has a ceiling value of $25,163.52 and a period of performance through July 31, 2025. Agilent, a global leader in life sciences and applied chemical instrumentation, will provide HPLC system maintenance, repair, and...
- This is a delivery order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Agilent Technologies Inc. for a service agreement to maintain the agency's analytical liquid chromatography mass spectrometry (LCMS) units. The $13,212.48 firm-fixed-price contract has an ultimate completion date of December 14, 2021. It was awarded on December 15, 2020 under the Multiple Award Schedule (MAS) contract vehicle. The contract does not have a...
- This federal contract award, valued at $68,157.24, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Agilent Technologies Inc.'s Customer Service and Sales Division. The contract is a firm-fixed-price delivery order under the Scientific Equipment and Services (FSS-66) schedule of the General Services Administration (GSA). The award does not have a set-aside designation, indicating full and open competition. Agilent Technologies Inc....
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Agilent Technologies Inc. The award, with a ceiling value of $80,859.16, is for the purchase of scientific instruments and equipment. Agilent Technologies Inc. is a subsidiary of the parent company Agilent Technologies, Inc., a global provider of analytical instruments, software, services, and consumables for laboratory use. The contract is a firm...
- This federal contract award is to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., a global leader in life sciences, diagnostics, and applied chemical markets. The contract, with award ID 75N94019P00034, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, on October 30, 2018 for $11,661.36 on a firm fixed price basis. The contract did not have a set-aside designation. Agilent...
- This federal contract award to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., is for the acquisition of a mass spectrometry guided HPLC (high-performance liquid chromatography) purification system for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency. The $198,829.63 firm fixed-price delivery order contract does not have a set-aside designation and was awarded under the Multiple Award...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $4,810 purchase order contract to Agilent Technologies Inc.'s Customer Service And Sales Division. As a prime contractor, Agilent Technologies Inc. will provide unspecified products or services to the NIH/NIDDK in support of the agency's biomedical research efforts. Performance will occur in Marshallton, Delaware over a one year base period...
- This federal contract award to Agilent Technologies Inc. was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to provide scientific equipment and services. The $13,308.08 firm fixed price delivery order falls under the existing Scientific Equipment and Services (FSS-66) Multiple Award Schedule contract held by Agilent. The contract does not have a set-aside designation, indicating it was competed on a full and open basis. Agilent, a...
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $11,661.36, was awarded to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc. The contract is a delivery order under the GSA Scientific Equipment and Services (FSS-66) schedule, with a firm fixed-price pricing type. The...
- This federal contract award, with ID GS07F0564X|HHSN275201700139U, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Agilent Technologies Inc., Customer Service and Sales Division. The $83,729.18 firm fixed-price delivery order falls under the Scientific Equipment and Services Federal Supply Schedule (FSS-66) contract vehicle. The award was not set aside for any special designation. The parent company, Agilent Technologies,...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $35,412.60 firm-fixed-price purchase order to Agilent Technologies Inc. for a service contract to provide an analytical liquid chromatography-mass spectrometry (LCMS) unit #3. The award was made on December 1, 2020, with a final completion date of May 2, 2025. This contract was not set aside for any particular business size or type. Agilent Technologies Inc. is a global leader in life sciences and analytical instrumentation that has a significant federal contracting presence, providing specialized scientific equipment and maintenance services to numerous government agencies. This specific award is part of the NIDDK's work in biomedical research related to diabetes, digestive, and kidney diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Terminate for Convenience | $0 | 5/2/25 | |
| P00006 | Exercise an Option | $7.1k | 11/18/24 | |
| P00005 | Vendor DUNS or Name Change - Non-Novation | $0 | 12/6/23 | |
| P00004 | Exercise an Option | $7.1k | 10/30/23 | |
| P00003 | Exercise an Option | $7.1k | 10/18/22 |